Stefan Grünert
Impact in
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- Antimicrobial Peptides and Activities 2
- Oncology 8
- Cancer Cells and Metastasis 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Hartmut BeugMartin JechlingerNorbert KrautMargit A. HuberNinel AzoiteiThomas WirthHubert PehambergerAndreas Sommer
- Journals
- The EMBO Journal (3 papers)Oncogene (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Journal of Clinical Investigation (2 papers)Cancers (1 paper)
- Partner nations
- AustriaUnited KingdomUnited States
In The Last Decade
Stefan Grünert
19 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 925
- Oncology 1.5k
- Molecular Biology 2.6k
- Immunology and Allergy 138
- Cell Biology 312
Countries citing papers authored by Stefan Grünert
This map shows the geographic impact of Stefan Grünert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Grünert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Grünert more than expected).
Fields of papers citing papers by Stefan Grünert
This network shows the impact of papers produced by Stefan Grünert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Grünert. The network helps show where Stefan Grünert may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Grünert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2019 | 10 | |
| 7 | 2018 | 14 | |
| 8 | 2007 | 18 | |
| 9 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression Hit paper breakdown → | 2004 | 734 |
| 10 | 2004 | 42 | |
| 11 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression Hit paper breakdown → | 2004 | 780 |
| 12 | 2003 | 231 | |
| 13 | Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis Hit paper breakdown → | 2003 | 568 |
| 14 | 2002 | 60 | |
| 15 | Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis Hit paper breakdown → | 2002 | 591 |
| 16 | 2000 | 297 | |
| 17 | 1996 | 62 | |
| 18 | 1995 | 228 | |
| 19 | 1994 | 92 | |
| 20 | 1993 | 15 |
About Stefan Grünert
Stefan Grünert is a scholar working on Microbiology, Oncology, Molecular Biology, Cancer Research and Immunology and Allergy, having authored 20 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), TGF-β signaling in diseases (5 papers), RNA and protein synthesis mechanisms (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Antimicrobial Peptides and Activities (2 papers), Cellular Mechanics and Interactions (2 papers), NF-κB Signaling Pathways (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Cancer Research (925 citations), Oncology (1.5k citations), Molecular Biology (2.6k citations), Immunology and Allergy (138 citations) and Cell Biology (312 citations). Stefan Grünert has collaborated with scholars based in Austria, United Kingdom and United States. Frequent co-authors include Hartmut Beug, Martin Jechlinger, Norbert Kraut, Margit A. Huber, Ninel Azoitei, Thomas Wirth, Hubert Pehamberger, Andreas Sommer, Bernd Baumann and Daniel St Johnston. Their work appears in journals such as The EMBO Journal, Oncogene, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Clinical Investigation and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.